News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News May 20, 2026
Gibson Dunn Advises James Murdoch’s Lupa Systems on Acquisition of New York Magazine, Vox Media Podcast Network, and Vox
Gibson Dunn is advising Lupa Systems, James Murdoch's media and technology holding company, on its acquisition of New York Magazine, the Vox Media Podcast Network, and Vox from the digital media group Vox Media.
Firm News April 15, 2026
Gibson Dunn Advises American Ocean Minerals on Merger with Odyssey Marine Exploration
Gibson Dunn is advising American Ocean Minerals Corporation on its merger with Odyssey Marine Exploration Inc. creating a $1 billion U.S.-controlled deep-sea critical minerals platform.
Firm News April 6, 2026
Gibson Dunn Advises Publicis Groupe on Its Acquisition of 160over90
Gibson Dunn is advising Publicis Groupe on its acquisition of 160over90, the premier global sports and culture-first agency.
Client Alert March 30, 2026
FTC and DOJ Request Public Comment on Potential Modifications to Premerger Notification
The request for public comment signals that, notwithstanding the recent vacatur of the 2024 updates to the HSR process, the Agencies continue to pursue revisions to the HSR framework and are seeking input on additional potential changes to the HSR Form and accompanying rules to address perceived gaps in HSR merger review.
Firm News March 25, 2026
Gibson Dunn Antitrust Team Advises Merck on $6.7 Billion Acquisition of Terns Pharmaceuticals, Inc.
A Gibson Dunn antitrust team is advising Merck on its $6.7 billion acquisition of Terns Pharmaceuticals, Inc., a clinical-stage oncology company.
Client Alert March 19, 2026
HSR Update: Fifth Circuit Order Enables Parties to Revert Immediately to Pre-2024 HSR Form
The FTC will continue to accept filings submitted under the 2024 Rule on a voluntary basis. The agency has not …
Firm News March 18, 2026
Gibson Dunn Advises Blue Owl and RadiusDC on Acquisition of phoenixNAP’s Phoenix Data Center and Colocation Business
Gibson Dunn is advising Blue Owl and RadiusDC on the acquisition of phoenixNAP's Phoenix data center and colocation business.
Firm News March 3, 2026
Gibson Dunn Advises Gyre Therapeutics on Its Acquisition of Cullgen
Gibson Dunn is advising Gyre Therapeutics, Inc., an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases, on its acquisition of Cullgen Inc. The all-stock transaction is valued at approximately $300 million.